Keiretsu Forum Sponsors Quix Labs at the Innovation Funders Showcase During Angel Capital Association's Annual Summit
April 24 2024 - 7:08AM
Keiretsu Forum Mid-Atlantic, South-East, and Texas regions proudly
announce their sponsorship of Quix Labs at the upcoming Innovation
Funders Showcase during the 2024 Angel Capital Association (ACA)
Summit. This event marks a significant step for Quix Labs' to
secure additional funding to accelerate the rollout of their
revolutionary tobacco free vape solution in the UK with plans to
soon expand into the EU and then the US, thereby advancing their
mission to dramatically decrease smoking and nicotine dependencies
for young adults.
Pioneering a Smoke-and-Nicotine-Free
Future
Founded during the height of the pandemic, Quix
Labs has rapidly become a beacon of innovation in smoking
alternative technology. With a mission spearheaded by a visionary
founder and bolstered by seasoned medical professionals, Quix Labs
has developed Quixotic, a groundbreaking reusable vaping device
designed to be the last vape its users will ever need.
Quixotic: The Vape Designed to Be Your
Last
Quixotic operates with Q-Pods, which are available
in four different nicotine strengths, tapering down to zero,
offering users a tailored approach in their journey to become
nicotine free. Approved and introduced in the UK in Q1 2024, this
device is the first of its kind to offer such a wide range of
nicotine options in a single, cost and user-friendly solution. Now
with approvals for sale in the UK and EU, and availability both
online and in pharmacies, Quixotic is poised to set new standards
in the industry.
Backed by Prominent Investors
Quix Labs' journey has been supported by members of
Keiretsu Forum, AJM Venture Group, and a family office in Long
Island, showcasing a strong backing from reputable investment
entities.
A Commitment to Innovation and
Partnership
"Supporting Quix Labs at the ACA Summit underscores
our commitment to fostering innovative solutions that promise not
only return on investment but also a profound societal impact,"
stated Howard Lubert, Area President, Keiretsu Forum. "We are
excited to showcase their potential to our extensive network of
angel investors."
The ACA Summit, scheduled to take place in
Columbus, Ohio from May 13-15, 2024, promises to be a pivotal event
for networking, investment opportunities, and showcasing
groundbreaking technologies.
About Keiretsu Forum Mid-Atlantic,
South-East, and Texas
Keiretsu Forum is the world’s largest private
equity angel investment network with 2000+ accredited investors in
34 North American and 23 International chapters, who have invested
more than $1B in early-stage companies in the last 23 years.
The Keiretsu Forum portfolio features Entrepreneurs
and Companies from Technology-(Internet, Software, Cyber Security,
SaaS, Mobile Systems, IoT, etc.), Life Sciences-(Pharma, Medical
Devices, Health IT, etc.), FinServ/FinTech, Consumer Products,
Clean-Green Energy, Consumer Products, & more!
About Quix Labs
Quix Labs is a consumer health startup that
partners with pharmacies and stop smoking services to educate and
provide smokers with smoking alternative technology (SAT). The
product is a reusable vaporization device that delivers to the
consumer a tobacco-free nicotine with four strengths tapering down
to zero. The company is revenue-generating and has initially
launched with a pilot in the United Kingdom.
Quix Labs launched in 2023 off the heals of seeing
the emerging new market of nicotine cessation after the rise in use
of smokeless nicotine products. The founding team includes
multi-time founders and over 50 years of experience in smoking
cessation.
For more information on the ACA Summit and Quix
Labs' participation, please contact:
Cindi SuteraAMS
Communicationscindis@amscommunications.net610-613-2773